Group One Trading
PRME icon

Group One Trading’s Prime Medicine PRME Stock Holding History

Group One Trading’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.2K Sell
24,766
-78,447
-76% -$299K ﹤0.01% 4861
2025
Q4 		$358K Buy
+103,213
New +$459K ﹤0.01% 3848
2024
Q3 		– Sell
-1,975
Closed -$9.15K – 7214
2024
Q2 		$10.2K Buy
+1,975
New +$12K ﹤0.01% 5637

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Group One Trading's PRME Position: Q1 2026 in Review

Group One Trading reduced its Prime Medicine (PRME) stake by 76% in Q1 2026, selling an estimated $299K and leaving 24,766 shares worth $86.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4861.

Group One Trading first reported a position in PRME in Q2 2024 and has held it in 3 quarters since. The position peaked at $358K in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Group One Trading held 24,766 shares of Prime Medicine worth $86.2K as of Q1 2026.
  • Group One Trading sold 78,447 Prime Medicine shares in Q1 2026, an estimated $299K.
  • Prime Medicine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4861 holding.
  • Group One Trading first reported a position in Prime Medicine in Q2 2024 and has held it in 3 quarters since.
  • Group One Trading's Prime Medicine position peaked at $358K in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.